Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish Population

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Eriksen, Kirsten T ^a   Raaschou Nielsen, Ole ^a   McLaughlin, Joseph K ^b   Lipworth, Loren ^b   Tjønneland, Anne ^a   Overvad, Kim ^c   Sørensen, Mette ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CAUSAL ATTRIBUTION; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DANISH; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE;

AGED; ALKANESULFONIC ACIDS; CAPRYLATES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DENMARK; ENVIRONMENTAL EXPOSURE; FEMALE; FLUOROCARBONS; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE;

EID: 84874149354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056969     Document Type: Article

References (27)

1. Butenhoff JL, Olsen GW, Pfahles-Hutchens A, (2006) The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ Health Perspect 114: 1776-1782.
2. U.S. Environmental Protection Agency. Perfluorooctanoic Acid (PFOA)- Basic Information. http://www.epa.gov/oppt/pfoa/pubs/pfoainfo.html. Accessed July 12.
3. Calafat AM, Kuklenyik Z, Caudill SP, Reidy JA, Needham LL, (2006) Perfluoroche micals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol 40: 2128-2134.
4. Calafat AM, Needham LL, Kuklenyik Z, Reidy JA, Tully JS, et al. (2006) Perfluorinated chemicals in selected residents of the American continent. Chemosphere 63: 490-496.
5. Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, et al. (2004) Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38: 4489-4495.
6. Midasch O, Schettgen T, Angerer J, (2006) Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. Int J Hyg Environ Health 209: 489-496.
7. Steenland K, Fletcher T, Savitz DA, (2010) Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118: 1100-1108.
8. Costa G, Sartori S, Consonni D, (2009) Thirty years of medical surveillance in perfluooctanoic acid production workers. J Occup Environ Med 51: 364-372.
9. Olsen GW, Burris JM, Burlew MM, Mandel JH, (2000) Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem Toxicol 23: 603-620.
10. Olsen GW, Burris JM, Burlew MM, Mandel JH, (2003) Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45: 260-270.
11. Olsen GW, Zobel LR, (2007) Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81: 231-246.
12. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR, (2007) Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 49: 872-879.
13. Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, et al. (2007) Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med 49: 1086-1096.
14. Frisbee SJ, Shankar A, Knox SS, Steenland K, Savitz DA, et al. (2010) Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med 164: 860-869.
15. Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V, (2009) Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol 170: 1268-1278.
16. Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, et al. (2006) Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med 48: 771-779.
17. Nelson JW, Hatch EE, Webster TF, (2010) Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118: 197-202.
18. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, et al. (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99: 366-394.
19. Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, et al. (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35: 432-441.
20. Eriksen KT, Sorensen M, McLaughlin JK, Lipworth L, Tjonneland A, et al. (2009) Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 101: 605-609.
21. Ehresman DJ, Froehlich JW, Olsen GW, Chang SC, Butenhoff JL, (2007) Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res 103: 176-184.
22. Hornung RW, Reed LD, (1990) Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 5: 46-51.
23. Eriksen KT, Sorensen M, McLaughlin JK, Tjonneland A, Overvad K, et al. (2011) Determinants of plasma PFOA and PFOS levels among 652 Danish men. Environ Sci Technol 45: 8137-8143.
24. Kennedy GL Jr, Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, et al. (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34: 351-384.
25. Palmer CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF, (1998) Peroxisome proliferator activated receptor-alpha expression in human liver. Mol Pharmacol 53: 14-22.
26. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, et al. (2007) Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115: 1298-1305.
27. Chateau-Degat ML, Pereg D, Dallaire R, Ayotte P, Dery S, et al. (2010) Effects of perfluorooctanesulfonate exposure on plasma lipid levels in the Inuit population of Nunavik (Northern Quebec). Environ Res 110: 710-717.